{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:52:53Z","timestamp":1790632373239,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-3-024"],"award-info":[{"award-number":["2016-I2M-3-024"]}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["2017RZ0047"],"award-info":[{"award-number":["2017RZ0047"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science and Technology of China","award":["2014EG150133"],"award-info":[{"award-number":["2014EG150133"]}]},{"name":"Funding of Sichuan Science and Technology Department","award":["018SZ0395"],"award-info":[{"award-number":["018SZ0395"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00251-021-01213-w","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T11:09:03Z","timestamp":1615547343000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Variation and expression of HLA-DPB1 gene in HBV infection"],"prefix":"10.1007","volume":"73","author":[{"given":"Guojin","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"1213_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.it.2018.10.008","volume":"39","author":"M Anczurowski","year":"2018","unstructured":"Anczurowski M, Hirano N (2018) Mechanisms of HLA-DP antigen processing and presentation revisited. Trends Immunol 39:960\u2013964","journal-title":"Trends Immunol"},{"key":"1213_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3346\/jkms.2008.23.5.838","volume":"23","author":"SW Cho","year":"2008","unstructured":"Cho SW, Cheong JY, Ju YS, Oh DH, Suh YJ, Lee KW (2008) Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J Korean Med Sci 23:838\u2013844","journal-title":"J Korean Med Sci"},{"issue":"Suppl 1","key":"1213_CR3","first-page":"7","volume":"28","author":"Y Cui","year":"2013","unstructured":"Cui Y, Jia J (2013) Update on epidemiology of hepatitis B and C in China. J GastroenterolHepatol 28(Suppl 1):7\u201310","journal-title":"J GastroenterolHepatol"},{"key":"1213_CR4","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.3748\/wjg.v20.i25.8179","volume":"20","author":"L Doganay","year":"2014","unstructured":"Doganay L, Fejzullahu A, Katrinli S, Yilmaz Enc F, Ozturk O, Colak Y, Ulasoglu C, Tuncer I, DinlerDoganay G (2014) Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B. World J Gastroenterol 20:8179\u20138186","journal-title":"World J Gastroenterol"},{"key":"1213_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1034\/j.1600-0676.2001.021002143.x","volume":"21","author":"PT Donaldson","year":"2001","unstructured":"Donaldson PT, Ho S, Williams R, Johnson PJ (2001) HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver 21:143\u2013148","journal-title":"Liver"},{"key":"1213_CR6","doi-asserted-by":"crossref","unstructured":"Hiramatsu K, Matsuda H, Nemoto T, Nosaka T, Saito Y, Naito T, Takahashi K, Ofuji K, Ohtani M, Suto H et al (2017) Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C. J Med Virol","DOI":"10.1002\/jmv.24814"},{"key":"1213_CR7","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.24799","volume":"55","author":"L Hu","year":"2012","unstructured":"Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z (2012) Genetic variants in human leukocyte antigen\/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55:1426\u20131431","journal-title":"Hepatology"},{"key":"1213_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/apt.15887","volume":"52","author":"YH Huang","year":"2020","unstructured":"Huang YH, Liao SF, Khor SS, Lin YJ, Chen HY, Chang YH, Huang YH, Lu SN, Lee HW, Ko WY et al (2020) Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Aliment PharmacolTher 52:682\u2013691","journal-title":"Aliment PharmacolTher"},{"key":"1213_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ng.348","volume":"41","author":"Y Kamatani","year":"2009","unstructured":"Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H et al (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41:591\u2013595","journal-title":"Nat Genet"},{"key":"1213_CR10","first-page":"351","volume":"80","author":"S Katrinli","year":"2017","unstructured":"Katrinli S (2017) NilayKaratasErkut G, Ozdil K, Yilmaz Enc F, Ozturk O, Kahraman R, Tuncer I, DinlerDoganay G, Doganay L: HLA DPB1 15:01 allele predicts spontaneus hepatitis B surface antigen seroconversion. Acta Gastroenterol Belg 80:351\u2013355","journal-title":"Acta Gastroenterol Belg"},{"key":"1213_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-017-1318-1","volume":"15","author":"X Li","year":"2017","unstructured":"Li X, Zhou L, Gu L, Gu Y, Chen L, Lian Y, Huang Y (2017) Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment. J Transl Med 15:220","journal-title":"J Transl Med"},{"key":"1213_CR12","doi-asserted-by":"publisher","first-page":"e111677","DOI":"10.1371\/journal.pone.0111677","volume":"9","author":"Y Liao","year":"2014","unstructured":"Liao Y, Cai B, Li Y, Chen J, Tao C, Huang H, Wang L (2014) Association of HLA-DP\/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis. PLoS One 9:e111677","journal-title":"PLoS One"},{"key":"1213_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12985-017-0865-7","volume":"14","author":"Y Mardian","year":"2017","unstructured":"Mardian Y, Yano Y, Wasityastuti W, Ratnasari N, Liang Y, Putri WA, Triyono T, Hayashi Y (2017) Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study. Virol J 14:201","journal-title":"Virol J"},{"key":"1213_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jmv.25011","volume":"90","author":"H Matsuda","year":"2018","unstructured":"Matsuda H, Hiramatsu K, Akazawa Y, Nosaka T, Saito Y, Ozaki Y, Hayama R, Takahashi K, Naito T, Ofuji K et al (2018) Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents. J Med Virol 90:712\u2013720","journal-title":"J Med Virol"},{"key":"1213_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcimb.2020.00055","volume":"10","author":"A Niehrs","year":"2020","unstructured":"Niehrs A, Altfeld M (2020) Regulation of NK-cell function by HLA class II. Front Cell Infect Microbiol 10:55","journal-title":"Front Cell Infect Microbiol"},{"key":"1213_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41590-019-0448-4","volume":"20","author":"A Niehrs","year":"2019","unstructured":"Niehrs A, Garcia-Beltran WF, Norman PJ, Watson GM, Holzemer A, Chapel A, Richert L, Pommerening-Roser A, Korner C, Ozawa M et al (2019) A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44. Nat Immunol 20:1129\u20131137","journal-title":"Nat Immunol"},{"key":"1213_CR17","doi-asserted-by":"publisher","first-page":"24767","DOI":"10.1038\/srep24767","volume":"6","author":"N Nishida","year":"2016","unstructured":"Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H et al (2016) Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep 6:24767","journal-title":"Sci Rep"},{"key":"1213_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/tan.12684","volume":"86","author":"N Nishida","year":"2015","unstructured":"Nishida N, Ohashi J, Sugiyama M, Tsuchiura T, Yamamoto K, Hino K, Honda M, Kaneko S, Yatsuhashi H, Koike K et al (2015) Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals. Tissue Antigens 86:406\u2013412","journal-title":"Tissue Antigens"},{"key":"1213_CR19","doi-asserted-by":"publisher","first-page":"e86449","DOI":"10.1371\/journal.pone.0086449","volume":"9","author":"N Nishida","year":"2014","unstructured":"Nishida N, Sawai H, Kashiwase K, Minami M, Sugiyama M, Seto WK, Yuen MF, Posuwan N, Poovorawan Y, Ahn SH et al (2014) New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia. PLoS One 9:e86449","journal-title":"PLoS One"},{"key":"1213_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/hep.29876","volume":"68","author":"N Nishida","year":"2018","unstructured":"Nishida N, Sugiyama M, Sawai H, Nishina S, Sakai A, Ohashi J, Khor SS, Kakisaka K, Tsuchiura T, Hino K et al (2018) Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology 68:848\u2013858","journal-title":"Hepatology"},{"key":"1213_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/gene.2011.11","volume":"12","author":"TR O'Brien","year":"2011","unstructured":"O\u2019Brien TR, Kohaar I, Pfeiffer RM, Maeder D, Yeager M, Schadt EE, Prokunina-Olsson L (2011) Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun 12:428\u2013433","journal-title":"Genes Immun"},{"key":"1213_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12967-018-1716-z","volume":"16","author":"G Ou","year":"2018","unstructured":"Ou G, Xu H, Yu H, Liu X, Yang L, Ji X, Wang J, Liu Z (2018) The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection. J Transl Med 16:362","journal-title":"J Transl Med"},{"key":"1213_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jvh.13012","volume":"26","author":"G Ou","year":"2019","unstructured":"Ou G, Liu X, Yang L, Yu H, Ji X, Liu F, Xu H, Qian L, Wang J, Liu Z (2019) Relationship between HLA-DPA1 mRNA expression and susceptibility to hepatitis B. J Viral Hepat 26:155\u2013161","journal-title":"J Viral Hepat"},{"key":"1213_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.humimm.2011.10.013","volume":"73","author":"M Paximadis","year":"2012","unstructured":"Paximadis M, Mathebula TY, Gentle NL, Vardas E, Colvin M, Gray CM, Tiemessen CT, Puren A (2012) Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. Hum Immunol 73:80\u201392","journal-title":"Hum Immunol"},{"key":"1213_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1500140","volume":"373","author":"EW Petersdorf","year":"2015","unstructured":"Petersdorf EW, Malkki M (2015) O\u2019HUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P: High HLA-DP expression and graft-versus-host disease. N Engl J Med 373:599\u2013609","journal-title":"N Engl J Med"},{"key":"1213_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.humimm.2017.11.001","volume":"79","author":"B Schone","year":"2018","unstructured":"Schone B, Bergmann S, Lang K, Wagner I, Schmidt AH, Petersdorf EW, Lange V (2018) Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: linkage analysis of over 32,000 samples. Hum Immunol 79:20\u201327","journal-title":"Hum Immunol"},{"key":"1213_CR27","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546\u20131555","journal-title":"Lancet"},{"key":"1213_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","volume":"101","author":"HR Shin","year":"2010","unstructured":"Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101:579\u2013585","journal-title":"Cancer Sci"},{"key":"1213_CR29","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1128\/JVI.00406-12","volume":"86","author":"R Thomas","year":"2012","unstructured":"Thomas R, Thio CL, Apps R, Qi Y, Gao X, Marti D, Stein JL, Soderberg KA, Moody MA, Goedert JJ et al (2012) A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 86:6979\u20136985","journal-title":"J Virol"},{"key":"1213_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY (2014) The global burden of liver disease: the major impact of China. Hepatology 60:2099\u20132108","journal-title":"Hepatology"},{"key":"1213_CR31","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1016\/j.vaccine.2019.09.001","volume":"37","author":"LY Wang","year":"2019","unstructured":"Wang LY, Chen CF, Wu TW, Lai SK, Chu CC, Lin HH (2019) Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. Vaccine 37:6435\u20136440","journal-title":"Vaccine"},{"key":"1213_CR32","doi-asserted-by":"publisher","first-page":"15244","DOI":"10.1038\/ncomms15244","volume":"8","author":"Y Yamashita","year":"2017","unstructured":"Yamashita Y, Anczurowski M, Nakatsugawa M, Tanaka M, Kagoya Y, Sinha A, Chamoto K, Ochi T, Guo T, Saso K et al (2017) HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nat Commun 8:15244","journal-title":"Nat Commun"},{"key":"1213_CR33","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.3748\/wjg.v18.i24.3119","volume":"18","author":"ZH Yan","year":"2012","unstructured":"Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM (2012) Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis. World J Gastroenterol 18:3119\u20133128","journal-title":"World J Gastroenterol"},{"key":"1213_CR34","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1038\/srep14933","volume":"5","author":"L Yu","year":"2015","unstructured":"Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ, Hu YX, Mu M, Wang B et al (2015) Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Sci Rep 5:14933","journal-title":"Sci Rep"},{"key":"1213_CR35","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.1128\/JVI.02073-13","volume":"87","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X et al (2013) HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol 87:12176\u201312186","journal-title":"J Virol"},{"key":"1213_CR36","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/hmg\/ddw003","volume":"25","author":"M Zhu","year":"2016","unstructured":"Zhu M, Dai J, Wang C, Wang Y, Qin N, Ma H, Song C, Zhai X, Yang Y, Liu J et al (2016) Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese. Hum Mol Genet 25:1225\u20131232","journal-title":"Hum Mol Genet"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-021-01213-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00251-021-01213-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-021-01213-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T14:03:18Z","timestamp":1620482598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00251-021-01213-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1007\/s00251-021-01213-w","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"6 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethic committees of the Institution of Blood Transfusion, CAMS&PUMC, and was conducted according to the principles of the Declaration of Helsinki. All participants provided written informed consent before enrolment, and the study\u2019s protocol was approved by the ethic committees of the Institution of Blood Transfusion, CAMS&PUMC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}